中国当代医药Issue(30)：68-69,72,3.
依托考昔和美洛昔康治疗急性痛风的临床效果以及安全性分析
Clinical efficacy and safety of etoricoxib and meloxicam in treating acute gout
郭迪斌 1居艳娟 1李荣平 1谷晓晶1
作者信息
- 1. 赣南医学院第一附属医院风湿免疫科，江西赣州 341000
- 折叠
摘要
Abstract
Objective To analyze the clinical effect and safety of etoricoxib and meloxicam in treating acute gout. Methods 120 cases of patients with acute gout treated in our hospital from January 2010 to January 2013 were selected as research objects and were divided into etoricoxib group and meloxicam group randomly,each group for 60 cases. Etoricoxib group were treated with etoricoxib,120 mg/d.Meloxicam group were treated with meloxicam,15 mg/d.The self score of pain of patients was measured,and the adverse reactions were recorded. Results After treatment,the joint pain scores of two groups were down,and etoricoxib group improved more better than that of meloxicam group,the differences were sinificant (P<0.05).The incidence of etoricoxib group was 30.0%,and the meloxicam group was 33.3%, there was no significant difference between the two groups (P>0.05). Conclusion The clinical efficacy of etoricoxib is better than that of meloxicam.关键词
依托考昔/美洛昔康/急性痛风/安全性Key words
Etoricoxib/Meloxicam/Acute gout/Safety分类
医药卫生引用本文复制引用
郭迪斌,居艳娟,李荣平,谷晓晶..依托考昔和美洛昔康治疗急性痛风的临床效果以及安全性分析[J].中国当代医药,2014,(30):68-69,72,3.
